Exos Asset Management’s Biote Corp BTMD Stock Holding History

Exos Asset Management’s Portfolio BTMD Stock Details BTMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-295,898	Closed	-$2.92M	–	302
2022 Q1	$2.92M	Buy	295,898 +13,080	+5%	+$129K	1.25%	17
2021 Q4	$2.77M	Buy	282,818 +199,944	+241%	+$1.95M	1.43%	8
2021 Q3	$807K	Hold	82,874	–	–	0.43%	69
2021 Q2	$802K	Buy	+82,874	New	+$813K	0.42%	49

Other funds holding BTMD

Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TPMI

Tilden Park Management I New York $5.38M AUM 28.49% 1-Year Est. Return

Exos Asset Management's BTMD Position: Q2 2022 in Review

Exos Asset Management sold out of Biote Corp (BTMD) in Q2 2022, closing a stake of 295,898 shares — an estimated $2.92M sold.

Exos Asset Management first reported a position in BTMD in Q2 2021 and held it in 4 quarters. The position peaked at $2.92M in Q1 2022. 12 funds tracked by Wall St. Rank hold BTMD as of Q2 2022.

Exos Asset Management reported no remaining Biote Corp position as of Q2 2022 after selling out during the quarter.
Exos Asset Management sold 295,898 Biote Corp shares in Q2 2022, an estimated $2.92M.
Exos Asset Management first reported a position in Biote Corp in Q2 2021 and held it in 4 quarters.
Exos Asset Management's Biote Corp position peaked at $2.92M in Q1 2022.
12 funds tracked by Wall St. Rank held Biote Corp as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.